Dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (EPOCH) with or without rituximab as first-line therapy for aggressive non-Hodgkin lymphoma. Lamar ZS, Fino N, Palmer J, Gruber L, Morris BB, Raetskaya-Solntseva O, Kennedy L, Vaidya R, Hurd D, Zamkoff K.. Clin Lymphoma Myeloma Leuk. 2016;16(2):76-81.
Timing of salvage therapy and autologous hematopoietic cell transplant in relapsed hodgkin and non hodgkin lymphoma [abstract]. Lamar ZS, Fino N, Hurd D, Howard D, McIver ZA, Phillips GL, Vaidya R.. Biol Blood Marrow Transplant. 2016;22(3 Suppl 1):S127-S128.
Single institution retrospective study of infusional etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin, (EPOCH) plus /- rituximab (R) as first line therapy for aggressive non-Hodgkin lymphoma [abstract]. Lamar ZS, Fitzgerald N, Palmer JM, Gruber L, RaetskayaSolntseva O, Kennedy L, Vaidya R, Zamkoff KW, Hurd DD.. J Clin Oncol. 2015;33(15 Suppl):e19514.
Ibrutinib and rituximab induced rapid response in refractory Richter syndrome. Lamar Z, Kennedy L, Kennedy B, Lynch M, Goad A, Hurd D, McIver Z.. Clin Case Rep. 2015;3(7):615-617.
A human bone marrow-derived stromal cell population with hemogenic potential [abstract]. Mokhtari S, Colletti EJ, Sanada C, Lamar ZS, Simmons PJ, Atala A, Krause DS, Zanjani ED, Porada CD, Almeida-Porada G.. Blood. 2015;126(23):1201.
Outcomes of second transplants for disease recurrence or for myelodysplasia (MDS) developing after an initial transplant (Tx) [abstract]. Naik S, D'Agostino R Jr, Lamar Z, Graham RM, Vatca M, Agnew E, Higgins A, Levitan D, Hurd D.. Biol Blood Marrow Transplant. 2012;18(2 Suppl 2):S340-S341.
Higher risk of severe drug-induced liver injury among Hispanic HIV-infected patients after initiation of highly active antiretroviral therapy. Lamar ZS, Nunez M.. J Int Assoc Physicians AIDS Care (Chic Ill). 2011;10(3):183-186.
Management of meningeal neoplasms: meningiomas and hemangiopericytomas. Lamar Z, Lesser GJ.. Curr Treat Options Oncol. 2011;12(3):230-239.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.
The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.
I find Dr. Lamar to be very professional and caring. She is careful to explain everything to me an my wife.
Excellent doctor compassionate, easy to understand.
My Primary Physician is with Novant Health and she initially set me up with an oncologist at Forsyth. I decided that I had more confidence in the care that I would receive at Baptist. it was one of the best decisions of my life..... actually, I think it saved my life. I thank God every day for all the good care and concern that everyone provided.
I have complete faith in Dr. Lamar, she is the best.
Dr. Lamar is an excellent doctor who cares about her patients. Very patient and caring. I feel that I got the best care I could have possibly received from her. Love her!!
Dr Lamar is WONDERFUL
*Dr. Lamar rocks!
All of Dr Lamar's team were exceptional. I never want to go through this cancer treatment with a transplant again, but should I have to, I'd want her team taking care of me.
I had a great experience
I love *Dr. Lamar I could not ask for a better more concerned person.
Cat is wonderful. She's as informed and helpful as Dr.Lamar, who is also wonderful.
Dr Lemar is wonderful. I am so thankful that she is my doctor!!!!!
Dr. Lamar is great.